View in EDS HTML Full Text PDF Full Text

Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.

Saved in:
Bibliographic Details
Title: Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
Authors: Burcher KM; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Bloomer CH; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Gavrila E; Wake Forest University School of Medicine, Winston-Salem, NC, USA., Kalada JM; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Chang MJ; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Gebeyehu RR; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Song AH; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Khoury LM; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Lycan TW; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Kinney R; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., D'Agostino R Jr; Division of Public Health Sciences, Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Bunch PM; Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Shukla K; Section on Molecular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Triozzi P; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Furdui CM; Section on Molecular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Zhang W; Center for Cancer Genomics and Precision Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Porosnicu M; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Jan 19; Vol. 16, pp. 17588359231217959. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38249330
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burcher+KM%22">Burcher KM</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Bloomer+CH%22">Bloomer CH</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Gavrila+E%22">Gavrila E</searchLink>; Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kalada+JM%22">Kalada JM</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Chang+MJ%22">Chang MJ</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Gebeyehu+RR%22">Gebeyehu RR</searchLink>; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Song+AH%22">Song AH</searchLink>; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Khoury+LM%22">Khoury LM</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Lycan+TW%22">Lycan TW</searchLink>; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kinney+R%22">Kinney R</searchLink>; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22D'Agostino+R+Jr%22">D'Agostino R Jr</searchLink>; Division of Public Health Sciences, Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Bunch+PM%22">Bunch PM</searchLink>; Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Shukla+K%22">Shukla K</searchLink>; Section on Molecular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Triozzi+P%22">Triozzi P</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Furdui+CM%22">Furdui CM</searchLink>; Section on Molecular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+W%22">Zhang W</searchLink>; Center for Cancer Genomics and Precision Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Porosnicu+M%22">Porosnicu M</searchLink>; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2024 Jan 19; Vol. 16, pp. 17588359231217959. <i>Date of Electronic Publication: </i>2024 Jan 19 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38249330
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17588359231217959
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17588359231217959
    Titles:
      – TitleFull: Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burcher KM
      – PersonEntity:
          Name:
            NameFull: Bloomer CH
      – PersonEntity:
          Name:
            NameFull: Gavrila E
      – PersonEntity:
          Name:
            NameFull: Kalada JM
      – PersonEntity:
          Name:
            NameFull: Chang MJ
      – PersonEntity:
          Name:
            NameFull: Gebeyehu RR
      – PersonEntity:
          Name:
            NameFull: Song AH
      – PersonEntity:
          Name:
            NameFull: Khoury LM
      – PersonEntity:
          Name:
            NameFull: Lycan TW
      – PersonEntity:
          Name:
            NameFull: Kinney R
      – PersonEntity:
          Name:
            NameFull: D'Agostino R Jr
      – PersonEntity:
          Name:
            NameFull: Bunch PM
      – PersonEntity:
          Name:
            NameFull: Shukla K
      – PersonEntity:
          Name:
            NameFull: Triozzi P
      – PersonEntity:
          Name:
            NameFull: Furdui CM
      – PersonEntity:
          Name:
            NameFull: Zhang W
      – PersonEntity:
          Name:
            NameFull: Porosnicu M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 01
              Text: 2024 Jan 19
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1758-8340
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Therapeutic advances in medical oncology
              Type: main
ResultId 1